Immobilization After an Anterior Glenohumeral Joint Dislocation With a Bankart Lesion
NCT ID: NCT01111500
Last Updated: 2012-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2007-07-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of the study is to evaluate the healing of the labrum in first time anterior glenohumeral joint dislocation with a Bankart lesion in young patients by comparing an external rotation brace to an internal rotation brace to immobilize the injured arm.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
external rotation immobilization
Patient will wear an external rotation brace to immobilize the injured arm.
Donjoy ER brace
Patients will wear an external rotation brace, the Donjoy ER brace, during treatment.
internal rotation immobilization
Patient will wear an internal rotation brace to immobilize the injured arm.
Thoraco brachial brace
Patients will wear an internal rotation brace, a thoraco brachial brace, during treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Donjoy ER brace
Patients will wear an external rotation brace, the Donjoy ER brace, during treatment.
Thoraco brachial brace
Patients will wear an internal rotation brace, a thoraco brachial brace, during treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \< 40 years old
* anterior glenohumeral joint dislocation proved by radiography
* dislocation needing a reduction manoeuvre
* home close to evaluation site for 24 months follow-up visits
* signed consent form
Exclusion Criteria
* Hill-Sachs lesion = or \> than 30%
* neurovascular deficit
* hypermobility
* pre-existing instability of the injured shoulder
* systemic neurological disease
* allergy to gadolinium
* functional sequel to the shoulder due to previous injury
* incapacitated adult patient
* minor patient
* home far from evaluation site
* refusal to sign the consent form
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital de l'Enfant-Jesus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pelet Stephane
Dr Stephane Pelet MD, PhD Orthopedic surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stéphane Pelet, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Enfant-Jésus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHA-Pavillon Enfant-Jésus
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Stéphane Pelet, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEJ-399
Identifier Type: -
Identifier Source: org_study_id